Goldman Sachs Group Inc Chroma Dex Corp. Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDXC
# of Institutions
94Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$18.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$16.5 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$15.7 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$6.87 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.09 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $362M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...